美国 · 财经报刊 · Investor's Business Daily
Merck And Moderna Diverge On Cancer Vaccine Results. Do They Still Have A Viable Drug?
Moderna and Merck stock diverged Friday as investors digested the early release of their cancer vaccine data. The post Merck And Moderna Diverge On Cancer Vaccine Results. Do They…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
